Literature DB >> 17968437

Role of obesity and adiposity in polycystic ovary syndrome.

E Diamanti-Kandarakis1.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age. Obesity may have a marked impact on both the development and progression of the syndrome. A high proportion of women with PCOS are obese. Regardless of the degree of obesity, women with PCOS are more likely to have central (abdominal) distribution of body fat, which is associated with insulin resistance and hyperandrogenaemia. PCOS is not only a reproductive disorder, but is also associated with significant increase in metabolic aberrations and cardiovascular risk factors. It has been shown that weight loss improves the metabolic and reproductive abnormalities that characterise the syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17968437     DOI: 10.1038/sj.ijo.0803730

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  35 in total

1.  Roux-en-Y Gastric Bypass Surgery in Patients with Polycystic Ovary Syndrome and Metabolic Syndrome.

Authors:  Sahruh Turkmen; Alebtekin Ahangari; Torbjörn Bäckstrom
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

Review 2.  Ovarian hormones and obesity.

Authors:  Brigitte Leeners; Nori Geary; Philippe N Tobler; Lori Asarian
Journal:  Hum Reprod Update       Date:  2017-05-01       Impact factor: 15.610

3.  Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.

Authors:  Thomas S Paterakis; Evanthia Diamanti-Kandarakis
Journal:  Curr Obes Rep       Date:  2014-12

Review 4.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

Review 5.  Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez
Journal:  Semin Reprod Med       Date:  2011-06-27       Impact factor: 1.303

6.  Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females.

Authors:  V Padmanabhan; A Veiga-Lopez; D H Abbott; S E Recabarren; C Herkimer
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

7.  Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China.

Authors:  Jia Huang; Renmin Ni; Xiaoli Chen; Lili Huang; Yaqin Mo; Dongzi Yang
Journal:  Reprod Biol Endocrinol       Date:  2010-11-17       Impact factor: 5.211

Review 8.  Animal models of the polycystic ovary syndrome phenotype.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez
Journal:  Steroids       Date:  2013-05-20       Impact factor: 2.668

Review 9.  Sexual differences in the control of energy homeostasis.

Authors:  Haifei Shi; Randy J Seeley; Deborah J Clegg
Journal:  Front Neuroendocrinol       Date:  2009-03-31       Impact factor: 8.606

10.  Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity--implication for polycystic ovary syndrome.

Authors:  Teresa L Steckler; Carol Herkimer; Daniel A Dumesic; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2008-10-30       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.